SUMMARY
In 34 patients of endogenous depression and 30 normal controls, the dexamethasone suppression test (DST) had a sensitivity of 67.6%, a specificity of 93.3% and a positive predictive power of 92%, which compares favourably with other diagnostic tests in clinical medicine. DST non-suppressors were significantly more depressed as compared to DST suppressors, had a higher incidence of suicidal attempts and past and family history of depression, needed electroconvulsive therapy more often, but showed a better response to therapy. Though the claim of the DST being a specific biological marker for endogenous depression remains controversial, it is an useful investigative tool for the diagnosis and treatment of endogenous depression.
Full Text
The Full Text of this article is available as a PDF (189.8 KB).